443956-16-9

Basic information

• Product Name: 3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde
• Synonyms: 3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde
• CAS NO: 443956-16-9
• Molecular Formula: C8H6N2O2S
• Molecular Weight: 194.21044
• Mol File: 443956-16-9.mol
• Article Data: 23

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde(443956-16-9)
• EPA Substance Registry System: 3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde(443956-16-9)

Safety Data

• Hazardous Substances Data: 443956-16-9(Hazardous Substances Data)

Usage

General Description

3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carbaldehyde is a chemical compound with a complex molecular structure. It belongs to the class of pyridothiazine compounds and is characterized by a carbonyl group at the 6-carbon position. This chemical is often used in organic synthesis and pharmaceutical research due to its potential biological activities. It may act as a versatile building block for the synthesis of various functionalized pyrido[3,2-b][1,4]thiazine derivatives, making it valuable in drug discovery and development. Additionally, its unique structure and reactive carbonyl group make it a promising candidate for the development of new drugs and therapeutic agents for various diseases and conditions. However, further research is needed to fully understand and harness the potential of this compound.

Upstream product

• 443956-13-6 methyl 3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carboxylate 
• 443956-15-8 6-hydroxymethyl-4H-pyrido[3,2-b][1,4]thiazin-3-one 

Downstream Products

• 443956-14-7 3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carboxylic acid 

Relevant articles and documents

TRICYCLIC ANTIBIOTICS

The invention relates to antibacterial compounds of formula (I) wherein U represents CH or N; W represents CH or N; R1 represents alkoxy, halogen or CN; ring A represents a pyrrolidin-1,3-diyl-, a piperidin-1,3-diyl or a morpholin-2,4-diyl group and B represents CH2; or ring A is selected from the groups drawn below: wherein R2 represents H, F or hydroxymethyl, and B is absent; G represents a group selected from the group consisting of —CH═CH-E, wherein Y1, Y2, Y3 and Z independently represent CH or N; Q represents O or S; and E represents phenyl which is mono- or di-substituted wherein the substituents are each independently halogen; and to pharmaceutically acceptable salts of such compounds.

5-Quinoline derivatives having an anti-bacterial activity

The present invention describes novel anti-bacterial compounds of the formula (I). These compounds are, amongst others, of interest as inhibitors of DNA gyrase and topoisomerases, for example of topoisomerase II and IV.

Antibacterial Agents

Naphthalene, quinoline, quinoaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.